loadpatents
name:-0.037087202072144
name:-0.019275188446045
name:-0.0092020034790039
Sharpe; Arlene H. Patent Filings

Sharpe; Arlene H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sharpe; Arlene H..The latest application filed is for "methods and compositions for treating cancer".

Company Profile
8.17.31
  • Sharpe; Arlene H. - Brookline MA
  • Sharpe; Arlene H. - Cambridge MA
  • Sharpe; Arlene H. - Boston MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Treating Cancer
App 20220213212 - Gazzaniga; Francesca S. ;   et al.
2022-07-07
Methods And Compositions For Treating Cancer
App 20220204604 - Gazzaniga; Francesca S. ;   et al.
2022-06-30
Agents that modulate immune cell activation and methods of use thereof
Grant 11,359,020 - Freeman , et al. June 14, 2
2022-06-14
Modulating Ptpn2 To Increase Immune Responses And Perturbing Gene Expression In Hematopoietic Stem Cell Lineages
App 20220081691 - Haining; William N. ;   et al.
2022-03-17
Methods Of Reducing Liver Pd-1-expressing Cd8+ T Cells Using Pd-1 Fc Fusion Proteins That Bind Fc Receptors
App 20220041726 - Freeman; Gordon J. ;   et al.
2022-02-10
Identification Of Gut Bacteria That Promote An Anti-tumor Response To Immunotherapy
App 20220023359 - Gazzaniga; Francesca S. ;   et al.
2022-01-27
Compositions And Methods For Modulating An Immune Response
App 20220010275 - Sharpe; Arlene H. ;   et al.
2022-01-13
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
Grant 11,207,393 - Sharpe , et al. December 28, 2
2021-12-28
Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors
Grant 11,124,569 - Freeman , et al. September 21, 2
2021-09-21
Compositions and methods for modulating an immune response
Grant 11,028,364 - Sage , et al. June 8, 2
2021-06-08
Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use
Grant 10,934,353 - Freeman , et al. March 2, 2
2021-03-02
Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators
Grant 10,927,410 - Haining , et al. February 23, 2
2021-02-23
Methods Of Treating Cancer Using Lsd1 Inhibitors In Combination With Immunotherapy
App 20200255527 - Kind Code
2020-08-13
Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
Grant 10,653,123 - Haining , et al.
2020-05-19
Anti-phosphotyrosinylated Pd-1 Antibodies And Uses Thereof
App 20200115452 - Freeman; Gordon J. ;   et al.
2020-04-16
Agents That Modulate Immune Cell Activation And Methods Of Use Thereof
App 20200095325 - Freeman; Gordon J. ;   et al.
2020-03-26
Compositions and methods for modulating an immune response
Grant 10,577,586 - Sharpe , et al.
2020-03-03
Anti-pd-l1 Monoclonal Antibodies And Fragments Thereof
App 20190330350 - Freeman; Gordon J. ;   et al.
2019-10-31
Agents that modulate immune cell activation and methods of use thereof
Grant 10,457,733 - Freeman , et al. Oc
2019-10-29
Anti-PD-L1 monoclonal antibodies and fragments thereof
Grant 10,202,454 - Freeman , et al. Feb
2019-02-12
Methods Of Reducing Liver Pd-1-expressing Cd8+ T Cells Using Pd-1 Fc Fusion Proteins That Bind Fc Receptors
App 20180355039 - Freeman; Gordon J. ;   et al.
2018-12-13
Compositions And Methods For Modulating An Immune Response
App 20180340147 - Sage; Peter T. ;   et al.
2018-11-29
Regulatory T Cell Pd-1 Modulation For Regulating T Cell Effector Immune Responses
App 20180303922 - Sharpe; Arlene H. ;   et al.
2018-10-25
Compositions and Methods for Modulating an Immune Response
App 20180230428 - Sharpe; Arlene H. ;   et al.
2018-08-16
Single Agent Anti-pd-l1 And Pd-l2 Dual Binding Antibodies And Methods Of Use
App 20180201680 - Freeman; Gordon J. ;   et al.
2018-07-19
Compositions and methods for modulating an immune response
Grant 9,885,016 - Sharpe , et al. February 6, 2
2018-02-06
Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use
Grant 9,845,356 - Freeman , et al. December 19, 2
2017-12-19
Compositions And Methods For Identification, Assessment, Prevention, And Treatment Of T-cell Exhaustion Using Cd39 Biomarkers And Modulators
App 20170233808 - Haining; William N. ;   et al.
2017-08-17
Methods and Compositions for Perturbing Gene Expression in Hematopoietic Stem Cell Lineages In Vivo
App 20170215392 - Haining; William N. ;   et al.
2017-08-03
Anti-pd-l1 Monoclonal Antibodies And Fragments Thereof
App 20160272712 - Freeman; Gordon J. ;   et al.
2016-09-22
Compositions and Methods for Modulating an Immune Response
App 20160032245 - Sharpe; Arlene H. ;   et al.
2016-02-04
Agents That Modulate Immune Cell Activation and Methods of Use Thereof
App 20150299322 - Freeman; Gordon J. ;   et al.
2015-10-22
Single Agent Anti-PD-L1 and PD-L2 Dual Binding Antibodies and Methods of Use
App 20150197571 - Freeman; Gordon J. ;   et al.
2015-07-16
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
App 20130022629 - Sharpe; Arlene H. ;   et al.
2013-01-24
Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
Grant 7,722,868 - Freeman , et al. May 25, 2
2010-05-25
Nucleic acid molecules encoding B7-1
Grant 7,619,078 - Sharpe , et al. November 17, 2
2009-11-17
Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
Grant 7,432,059 - Freeman , et al. October 7, 2
2008-10-07
Novel forms of T cell costimulatory molecules and uses therefor
App 20070106070 - Sharpe; Arlene H. ;   et al.
2007-05-10
Agents that modulate immune cell activation and methods of use thereof
App 20070065427 - Freeman; Gordon J. ;   et al.
2007-03-22
T cell costimulatory polypeptides containing alternative domains
Grant 7,153,934 - Sharpe , et al. December 26, 2
2006-12-26
B-7 domain-specific antibodies
App 20040192899 - Sharpe, Arlene H. ;   et al.
2004-09-30
Agents that modulate immune cell activation and methods of use thereof
App 20030232323 - Freeman, Gordon J. ;   et al.
2003-12-18
B7-specific antibodies
Grant 6,608,180 - Sharpe , et al. August 19, 2
2003-08-19
Novel forms of T cell costimulatory molecules and uses therefor
App 20030045703 - Sharpe, Arlene H. ;   et al.
2003-03-06
PD-L2 molecules: novel PD-1 ligands and uses therefor
App 20020110836 - Freeman, Gordon ;   et al.
2002-08-15
Novel forms of T cell costimulatory molecules and uses therefor
App 20020098542 - Sharpe, Arlene H. ;   et al.
2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed